Status:
COMPLETED
World Trade Center (WTC) CHEST
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
National Institute for Occupational Safety and Health (NIOSH/CDC)
Conditions:
Pulmonary Disease
Cardiac Disease
Eligibility:
All Genders
40+ years
Brief Summary
This project will evaluate the effects of World Trade Center (WTC) exposure in WTC responders 10-13 years following the events of 9/11. Prior studies have described persistent pulmonary function abnor...
Detailed Description
Serious illness and injury following the September 11, 2001 (9/11) attacks on the World Trade Center (WTC) affects thousands of responders who worked on the WTC rescue and recovery effort. During this...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- World Trade Center responders who are currently enrolled in the World Trade Center Health Program-Clinical Center of Excellence, formerly known as the WTC Medical Monitoring and Treatment Program
- Over the age of 39 years
Exclusion
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
1012 Patients enrolled
Trial Details
Trial ID
NCT01466218
Start Date
November 1 2011
End Date
June 1 2014
Last Update
July 1 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029